July 28, 2026

Travere Therapeutics, Inc. (TVTX) Stock Analysis: A Biotech with Strong Revenue Growth and Analyst Confidence

Travere Therapeutics, Inc. (NASDAQ: TVTX) is capturing the attention of investors within the healthcare sector, particularly in the biotechnology industry. With a market capitalization of $5.27 billion, Travere is positioned..

Alphatec Holdings, Inc. (ATEC) Stock Analysis: Investors Eye 83.66% Potential Upside

Alphatec Holdings, Inc. (NASDAQ: ATEC), a key player in the medical devices industry, is capturing investor attention with its impressive potential upside of 83.66%. This Carlsbad, California-based company is making..

Select Medical Holdings Corp (SEM) Stock Analysis: Navigating Stability with a 1.51% Dividend Yield

Select Medical Holdings Corporation (NYSE: SEM), a key player in the healthcare sector, specifically within the medical care facilities industry, presents a compelling case of stability and modest potential for..

NewAmsterdam Pharma (NAMS) Stock Analysis: Exploring the 67.69% Potential Upside for Investors

NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS), a promising player in the biotechnology sector, has caught the eye of investors with its ambitious pipeline and solid backing from analysts. As a..

ImmunityBio, Inc. (IBRX) Stock Analysis: Unveiling an 85% Upside Potential with Innovative Immunotherapies

ImmunityBio, Inc. (NASDAQ: IBRX) is carving a niche for itself in the biotechnology sector, focusing on revolutionizing how the immune system is activated to combat cancer and infectious diseases. Based..

Clover Health Investments (CLOV) Stock Analysis: Exploring the Growth Potential with a 62% Revenue Surge

Clover Health Investments, Corp (CLOV), a key player in the healthcare plans sector, is navigating through a transformative phase. With a market cap of $2.25 billion, Clover Health focuses on..

Progyny, Inc. (PGNY) Stock Analysis: Navigating the Fertility Benefits Market with Growth Potential

Progyny, Inc. (PGNY), a pioneer in fertility and family building benefits management, stands out in the healthcare plans sector with its innovative approach to providing comprehensive women’s health benefits in..

Haemonetics Corporation (HAE) Stock Analysis: Exploring a Potential 8.37% Upside in the Medical Devices Industry

Haemonetics Corporation (NYSE: HAE), a prominent player in the healthcare sector, specifically within the medical devices industry, is generating significant buzz among investors. With a market capitalization of $3.63 billion,..

BGM Group Ltd. (BGM): Investor Outlook on a Niche Healthcare Player Amidst 13.9% Revenue Growth

BGM Group Ltd. (BGM), a healthcare sector player operating out of China, has piqued investor interest with its recent financial performance, specifically a 13.9% revenue growth. As a company embedded..

Organon & Co. (OGN) Stock Analysis: Navigating the Healthcare Market with a Strong Return on Equity

Organon & Co. (NYSE: OGN) stands as a formidable player in the healthcare sector, specifically in the realm of general drug manufacturing. With a market capitalization of $3.56 billion, the..

National HealthCare Corporation (NHC) Stock Analysis: A $3.53 Billion Healthcare Giant with a Strong Dividend Appeal

National HealthCare Corporation (NHC), a prominent player in the healthcare sector, operates in the medical care facilities industry, providing a broad range of services through its skilled nursing facilities, assisted..

Denali Therapeutics Inc. (DNLI) Investor Outlook: Exploring the 45.58% Potential Upside

Denali Therapeutics Inc. (NASDAQ: DNLI), a prominent player in the biotechnology sector, is making waves with a compelling potential upside of 45.58%, attracting significant attention from investors eager to capitalize..

Twist Bioscience (TWST) Investor Outlook: Navigating a 6.89% Upside in the Dynamic Healthcare Sector

Twist Bioscience Corporation (NASDAQ: TWST) has been making waves in the healthcare sector, specifically within the diagnostics and research industry. With a current market capitalization of $5.39 billion, the company..

QuidelOrtho Corporation (QDEL)

⚠️ No article content returned.

..

BioCryst Pharmaceuticals, Inc. (BCRX) Investor Outlook: A Potential 119% Upside Awaits

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX), a trailblazer in the biotechnology sector, is garnering significant attention from investors, thanks to a promising pipeline and substantial potential upside. With a market capitalization..

Immunovant, Inc. (IMVT) Stock Analysis: Uncovering a Promising 18.57% Potential Upside

Immunovant, Inc. (NASDAQ: IMVT) is making waves in the biotechnology sector with its innovative approach to addressing autoimmune diseases. As a clinical-stage immunology company, Immunovant focuses on developing targeted therapies..

Veracyte, Inc. (VCYT) Stock Analysis: 21.5% Revenue Growth Signals Strong Performance in Healthcare Diagnostics

Veracyte, Inc. (NASDAQ: VCYT), a prominent player in the healthcare diagnostics sector, presents an intriguing opportunity for investors seeking exposure to the rapidly evolving field of genomic diagnostics. With a..

Agios Pharmaceuticals (AGIO) Stock Analysis: Navigating Growth with a 14.62% Potential Upside

For investors seeking exposure in the healthcare sector, particularly within the biotechnology industry, Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) presents a compelling opportunity. With a market capitalization of $2.2 billion, this..

HUTCHMED (China) Limited (HCM) Stock Analysis: Is a 102% Upside Within Reach for This Healthcare Innovator?

HUTCHMED (China) Limited (NASDAQ: HCM), a Hong Kong-based leader in the healthcare sector, is capturing the attention of investors with its compelling growth potential. Specializing in the discovery, development, and..

Acadia Healthcare (ACHC) Stock Analysis: What Investors Need to Know Amidst Strong Analyst Consensus

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) is a prominent player in the healthcare sector, specifically in the medical care facilities industry. With a market capitalization of $2.99 billion, the company..

Search

Funds

July 28, 2026

Search

Funds

July 28, 2026

FTSE 100

Funds